Skip to content
Peptide research

Matrixyl

Also known as Palmitoyl Pentapeptide-4
Category
Skin & Cosmetic
Administration routes
Topical
Regulatory status
Cosmetic ingredient

What it is

A topical peptide (palmitoyl pentapeptide-4) marketed to reduce fine lines and wrinkles. That benefit has solid human support, but collagen and texture claims are only moderate, and deeper repair or pigmentation claims are unproven. It appears well tolerated with minimal absorption, though data beyond 12 weeks is limited. As a cosmetic ingredient subject to FDA safety and labeling requirements, without drug approval, quality and efficacy vary by product.

Read Full record

Studied uses & evidence

Studied uses(6)

  • Reduces fine lines and wrinkles

    High

    Two human trials, including a 12-week randomized study, showed reduced wrinkles.

  • Stimulates collagen production

    Medium

    Well established in cell and animal studies, not yet confirmed by human skin biopsy.

  • Improves skin texture and firmness

    Medium

    Small human trials suggest improvement, though results are less robust than for wrinkles.

Evidence limits

Evidence Level
Moderate

Matrixyl has strong in vitro evidence for stimulating collagen and ECM production. Clinical evidence includes a well-designed 93-subject RCT (Robinson et al. 2005) and a smaller 21-subject RCT (Aruan et al. 2023), both showing improvements in wrinkles. However, a 2016 systematic review (Aldag et al.) noted that clinical relevance remains limited, with some endpoints only significant under relaxed statistical thresholds. Efficacy is demonstrated at very low concentrations (3 ppm).

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(7)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Generally very well tolerated with minimal reported side effects in clinical studies

    Low
  • Occasional mild tingling reported, typically attributed to other formula ingredients rather than the peptide itself

    Low
  • No allergic sensitization observed in repeated application studies

    Low
  • No known systemic toxicity — topical peptide with very low systemic absorption

    Low
  • Long-term safety data beyond 12 weeks is limited in published clinical trials

    Low
  • Efficacy may vary significantly between products due to differences in formulation, concentration, and delivery systems

    Moderate
  • As a cosmetic ingredient, manufacturing quality and concentration are not subject to pharmaceutical-grade regulation

    Moderate
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.